From high to low malaria transmission in Zanzibar-challenges and opportunities to achieve elimination. by Björkman, A et al.
LSHTM Research Online
Björkman, A; Shakely, D; Ali, AS; Morris, U; Mkali, H; Abbas, AK; Al-Mafazy, A-W; Haji, KA; Mcha,
J; Omar, R; +8 more... Cook, J; Elfving, K; Petzold, M; Sachs, MC; Aydin-Schmidt, B; Drakeley,
C; Msellem, M; Mårtensson, A; (2019) From high to low malaria transmission in Zanzibar-challenges
and opportunities to achieve elimination. BMC medicine, 17 (1). p. 14. ISSN 1741-7015 DOI:
https://doi.org/10.1186/s12916-018-1243-z
Downloaded from: http://researchonline.lshtm.ac.uk/4653403/
DOI: https://doi.org/10.1186/s12916-018-1243-z
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
RESEARCH ARTICLE Open Access
From high to low malaria transmission in
Zanzibar—challenges and opportunities to
achieve elimination
A. Björkman1*†, D. Shakely1,2†, A. S. Ali3, U. Morris1, H. Mkali4, A. K. Abbas3ˆ, A-W Al-Mafazy3, K. A. Haji3, J. Mcha3,
R. Omar3, J. Cook1,5, K. Elfving1,6, M. Petzold7, M. C. Sachs8, B. Aydin-Schmidt1, C. Drakeley5, M. Msellem9 and
A. Mårtensson10
Abstract
Background: Substantial global progress in the control of malaria in recent years has led to increased commitment
to its potential elimination. Whether this is possible in high transmission areas of sub-Saharan Africa remains unclear.
Zanzibar represents a unique case study of such attempt, where modern tools and strategies for malaria treatment and
vector control have been deployed since 2003.
Methods: We have studied temporal trends of comprehensive malariometric indices in two districts with over 100,000
inhabitants each. The analyses included triangulation of data from annual community-based cross-sectional surveys,
health management information systems, vital registry and entomological sentinel surveys.
Results: The interventions, with sustained high-community uptake, were temporally associated with a major malaria
decline, most pronounced between 2004 and 2007 and followed by a sustained state of low transmission. In 2015, the
Plasmodium falciparum community prevalence of 0.43% (95% CI 0.23–0.73) by microscopy or rapid diagnostic test
represented 96% reduction compared with that in 2003. The P. falciparum and P. malariae prevalence by PCR was 1.8%
(95% CI 1.3–2.3), and the annual P. falciparum incidence was estimated to 8 infections including 2.8 clinical episodes
per 1000 inhabitants. The total parasite load decreased over 1000-fold (99.9%) between 2003 and 2015. The incidence
of symptomatic malaria at health facilities decreased by 94% with a trend towards relatively higher incidence in age
groups > 5 years, a more pronounced seasonality and with reported travel history to/from Tanzania mainland as a
higher risk factor. All-cause mortality among children < 5 years decreased by 72% between 2002 and 2007
mainly following the introduction of artemisinin-based combination therapies whereas the main reduction in
malaria incidence followed upon the vector control interventions from 2006. Human biting rates decreased by
98% with a major shift towards outdoor biting by Anopheles arabiensis.
Conclusions: Zanzibar provides new evidence of the feasibility of reaching uniquely significant and sustainable
malaria reduction (pre-elimination) in a previously high endemic region in sub-Saharan Africa. The data highlight
constraints of optimistic prognostic modelling studies. New challenges, mainly with outdoor transmission, a large
asymptomatic parasite reservoir and imported infections, require novel tools and reoriented strategies to prevent a
rebound effect and achieve elimination.
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Background
Substantial progress has been made globally in reducing the
malaria burden during last decade [1] following the imple-
mentation and scaling up of vector control and effective treat-
ment. This has led to increased international commitment to
malaria elimination in several endemic areas [2, 3]. Elimin-
ation is considered feasible—and indeed has been achieved—
using existing tools in areas of low to moderate transmission
[4]. Whether elimination can be achieved in previously mod-
erate to high transmission areas, however, remains unclear.
According to the World Health Organization (WHO), “dem-
onstrated technical feasibility in such eco-epidemiological set-
tings is required [5].” Zanzibar with historically high malaria
transmission [6, 7] may represent a rather unique, useful and
valuable case study of such endeavour.
Zanzibar was among the first in sub-Saharan Africa to
roll out wide-scale modern control interventions [8], i.e.
the use of artemisinin-based combination therapy (ACT)
in 2003/2004 followed by long-lasting insecticidal nets
(LLINs), indoor residual spraying (IRS) and rapid diag-
nostic tests (RDTs) in 2005/2006 (Table 1).
We herein report to what extent reduction in malaria
transmission towards elimination has been achieved a
decade after the intensified malaria control and why and
where obstacles have emerged. Intervention uptake and
temporal trends of a comprehensive variety of malario-
metric indices are presented including molecular and
serological surveillance methods.
Methods
Study sites and malaria control interventions
Zanzibar (population 1.3 million) is an archipelago with two
main islands about 30 km from mainland Tanzania (Fig. 1).
The study was conducted in two rural districts, North A
(Unguja island) and Micheweni (Pemba island), each with a
population of approximately 100,000 people. The two dis-
tricts, selected in 2003, were considered to be representative
(e.g. mainly rural) for each of the two main islands of Zanzi-
bar. Each of the two districts included one public district
hospital, 13 public health care facilities and two private
clinics. There is access to a public health care facility within
5 km distance throughout Zanzibar.
Malaria transmission has historically been holoen-
demic with a trend towards hyperendemicity in the
1990s [6, 7, 9] and perennial with two peaks associated
with seasonal rainfalls in March–June and October–No-
vember. When the new interventions started in 2003,
Plasmodium falciparum was the pre-dominant malaria
species and Anopheles gambiae sensu lato, An. funestus
and An. coustani were the main vectors [7].
The introduction of new malaria control interventions
and strategies are presented in Table 1. The interven-
tions were implemented by the Zanzibar Malaria Con-
trol Programme (ZMCP), which became the Zanzibar
Malaria Elimination Programme (ZAMEP) in August
2013.
Cross-sectional surveys
Nine cross-sectional household surveys were conducted
in May–June between 2003 and 2015. The 2003 explora-
tory survey was conducted using a two-stage cluster
sample technique. First, shehias (smallest administrative
unit) and then the households were randomly selected
from the sampling frame obtained from the Office of
Government Statistics, Zanzibar [8]. This first survey in-
cluded 625 households. Sample size calculations for the
Table 1 Implementation of malaria control tools/strategies in Zanzibar between 2002 and 2016
Year, month Interventions
2002, November New antimalarial treatment policy: ACT; 1st line: ASAQ, 2nd line: AL
2003, September ACT deployment in all public health facilities.
2004 ITN distribution, geographically focused Intermittent preventive treatment in pregnancy (IPTp)
2005, September LLIN universal distribution to all children < 5 years and pregnant women
2006, July IRS (pyrethroid) aiming at annual universal coverage, in March before the main transmission season (after 2006)
2006 RDT provision to all public health facilities. LLIN provision initiated to all pregnant women and infants (9 months old) in
MCH clinics
2008 LLIN universal distribution—two nets per household
2009 New antimalarial treatment policy: 1st line: ASAQ, 2nd line: quinine Weekly reporting of malaria cases by mobile phone
from health care facilities (MEEDS)
2012 LLIN universal distribution—two nets per household IRS policy change: targeting hotspots only (carbamate 2012–2014,
pirimiphos-methyl 2015-) Malaria case investigation and reactive household RDT screening and LLIN distribution
2015 RDT and ACT provision to private health facilities (AMFm programme) Intermittent screening and treatment in pregnancy
(ISTp) replacing IPTp
2016 Larviciding in few selected sites New antimalarial treatment policy: ACT + primaquine (single low dose)
ACT artemisinin-based combination therapy, ASAQ artesunate-amodiaquine, AL arthemeter-lumefantrine, ITN insecticide-treated net, IRS indoor residual spraying,
RDT rapid diagnostic test, LLIN long-lasting insecticidal net, MEEDS malaria early epidemic detection system, AMFm affordable medicines for malaria, MCH mother
and child health
Björkman et al. BMC Medicine           (2019) 17:14 Page 2 of 15
follow-up surveys were adjusted according to changing
malaria prevalences. Those conducted in 2005 to 2007
were based on the proportion of children under five with
malaria parasitaemia in 2003, 9%, and an assumed rela-
tive error of 20%. The calculated number of households
to be included was 490 after adjusting for a design effect
of 2. The same shehias were selected in the follow-up
surveys, but each time with randomly selected house-
holds in proportion to the shehia size. From 2009 on-
wards, assuming 1% of households with at least one
member being parasite positive and 95% CI of +/− 1%
and 20% household members absent or refusing partici-
pation, the targeted sample sizes were 350 households.
Trained health personnel visited the selected house-
holds and conducted interviews (history of recent travel,
access to health care, use of LLIN, IRS coverage, etc.)
and blood sample collections (for malaria diagnosis by
blood smear or RDT, PCR and serological analyses, etc.)
upon written informed consent or proxy consent from
legal guardians for children ≤ 15 years.
Laboratory methods
Microscopic examination of Giemsa-stained thick blood
smears was used for parasitological screening in the
cross-sectional surveys 2003–2009. A P. falciparum-spe-
cific histidine-rich-protein 2 (HRP2)-based RDT (Para-
check) was used in 2011 followed by a combo RDT
detecting both HRP2 and pan-Plasmodium lactate de-
hydrogenase in 2013 (SD-Bioline) and 2015 (Malaria ag
combo).
Plasmodium detection by PCR was conducted on dried
filter paper blood spots after DNA extraction by Chelex®--
boiling method [10]. Cytb SYBR Green qPCR followed by
restriction fragment length polymorphism analysis [11]
was used for parasite screening and species determination.
Parasite density was estimated by qPCR [12].
Antibody responses to three P. falciparum blood stage
proteins (AMA-1, MSP-1 and GLURP) were determined
by ELISA on blood spots from the cross-sectional sur-
veys in 2009 and 2015 Mixture models were fitted to
OD ELISA responses assuming two Gaussian distribu-
tions and the seroprevalence cut-off defined as the mean
plus 3 standard deviations of the narrow, negative distri-
bution [13]. Models were fitted separately for each anti-
gen and combined to generate an overall seroprevalence
if positive to one or more antigen. Seroconversion rates
(SCRs) were estimated using reverse catalytic conversion
models.
Health facility and vital registry
Health facility data were collected monthly from the 26
public health care centres in the two districts (13 each)
throughout the study period (1999–2015) using the
Health Management Information System (HMIS) of the
Ministry of Health. This included numbers of malaria-
suspected patients, if malaria-tested and if confirmed by
microscopy or RDT as well as individual characteristics
of patients (age, sex, locality, etc.). In 2009, the HMIS
data reporting was reinforced by the “malaria early epi-
demic detection system” (MEEDS) with weekly reports
through a mobile phone reporting system (Table 1). Fi-
nally, from 2011, the “malaria case notification system”
(MCN) was implemented, including added epidemiology-
related information such as malaria risk factors (use of
LLINs, IRS coverage, recent travel history, etc.) [14]. Para-
sitological confirmation by microscopy or RDT was not
compulsory for all febrile patients until 2007. We there-
fore used positivity rates of those tested, rather than abso-
lute malaria cases in our trend analyses.
Vital registry records on total births and deaths (1998–
2014) were obtained from District Commissioner’s Office.
Fig. 1 North A and Micheweni districts on Unguja and
Pemba islands
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Demographic data were obtained from the Tanzanian Na-
tional Population and Housing Census.
Entomological and meteorological data
Entomological data were collected from 22 sentinel sites
(shehias) on Unguja and Pemba islands from 2005 on-
wards including North A and Micheweni districts. This
included collections of adult mosquitoes indoors (18–06
h) and outdoors (18–24 h) in randomly selected house-
holds and larvae in selected breeding grounds. Indoor
and outdoor human biting rates (HBRs) were deter-
mined by the human-landing catch method. In each sen-
tinel site, two human volunteer baits would sit in- and
outside two houses for four consecutive nights each
month. Additional collections by pyrethrum spray
light-traps and pit traps were also performed in some
sites. Mosquitoes were stored in paper cups for species
identification by PCR [15]. Sporozoites in the salivary
glands were identified by ELISA [16] Insecticide resist-
ance testing was conducted using the WHO guidelines
[17]. Anopheles larva were collected, allowed to develop
to adults, then exposed to the insecticides [15, 18].
Records of monthly rainfall for North A (1999–2015)
and Micheweni (2005–2015) were obtained from Zanzi-
bar Ministry of Communication and Transport through
the Tanzania Meteorological Agency.
Data management and analyses
Survey data were entered and validated using Microsoft
Access and Excel. Recent surveys were conducted via
tablets using Open Data kit. Statistical analyses were
performed using STATA versions 12 and 13, and R ver-
sion 3.2.2 (R Foundation for Statistical Computing,
Vienna, Austria). Some data represent aggregate data
from published articles [8, 15, 18, 19] and/or annual
malaria reports of ZMCP/ZAMEP [14].
Pearson correlation coefficients were calculated to as-
sess linear relationships between monthly rainfall and
malaria incidence. Poisson regression model was used to
assess malaria incidence and interaction of age (< 5 and
> 5 years of age) and calendar year. Exact binomial tests
were used where numbers were small (< 5). Otherwise,
the normal approximation was used to test for differ-
ences in proportions. Trends in prevalences over time
were tested using binomial logistic regression on the ag-
gregate counts. Fisher’s test was used to assess differen-
tial reduction between malaria species. Logistic
regression was used to assess the associations between
risk factors and infection.
Serological conversion rate (SCR) was used to estimate
the force of infection (incident malaria cases per popula-
tion time) using maximum likelihood methods [20].
Temporal change in SCR was identified using profile
likelihood plots and likelihood ratio tests against models
with no change [3, 21].
Annual parasite incidence or index (API), defined as
annual malaria cases per year per 1000 inhabitants, was
based on any parasite-positive infection, whether symp-
tomatic or not, whereas “clinical API” was based on re-
ported malaria confirmed clinical patients only.
Reproductive control rate/ratio (Rc) is normally de-
fined as number of new infections occurring from each
index infection. We have estimated this concept as “an-
nual Rc” in year X by calculating “annual incidence ra-
tio” (incidence year X/incidence year X − 1) or “annual
prevalence ratio” (prevalence year X/prevalence year X
− 1).
The sporozoite rate was based on human light-trap
catches throughout the year. However, after the intensi-
fied vector control in 2006, the sporozoite rates became
too low for a precise estimate. The rate was then extrap-
olated from the mean human asexual parasite prevalence
and density, assuming a linear correlation of the parasite
prevalence and non-linear correlation of the parasite
density [22] with the sporozoite rate (and infectious-
ness). The annual entomological inoculation rate (EIR)
was determined as the mean HBR × mean sporozoite
rate × 365 days.
Results
Intervention uptake
ACTs and RDTs were available in all health facilities
without any documented stock-out periods since their
respective implementation. There was high reported use
of insecticide-treated net (ITN)/LLIN in all age groups
in the cross-sectional surveys between 2006 and 2015 in
Micheweni and North A (mean 68% and 74%, respect-
ively) although children < 5 years were more likely to use
ITN/LLIN (81%) than individuals ≥ 5 years (69%) (p <
0.0001) (Additional file 1: Figure S1). After the first IRS
in July 2007, annual IRS was implemented in March
each year prior to the expected main rains and transmis-
sion season. The mean proportion of households report-
ing having had IRS within the previous year was 87.6%
from 2008 to 2011 in the two districts, 91% in Miche-
weni and 85% in North A—with annual ranges from 80
to 92% (Additional file 1: Figure S1). In 2013 and 2015
when IRS became more targeted, mainly to hotspot
areas, the mean coverages were 79% in Micheweni and
54% in North A.
Community-based parasite surveys
The overall microscopy- or RDT-determined parasite
prevalences of all ages at the cross-sectional surveys are
shown in Table 2 and Additional file 2: Table S1. Only P.
falciparum infections were detected. In 2015, the preva-
lences were 0.6% in Micheweni and 0.3% in North A
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(mean 0.43%, 95% CI 0.23–0.73). This represents 95.9%
and 96.6% (mean 95.8%; 24-fold) reductions in parasite
prevalences, respectively, as compared with 2003. The
main reduction occurred during 2006 and 2007 follow-
ing the introduction of LLINs and IRS, after which a low
prevalence was maintained, averaging 0.45% in Miche-
weni and 0.18% in North A. P. falciparum gametocyte
carriage was detected at low prevalences (< 1%) in 2003–
2006, but not in 2008–2009. The P. falciparum parasite
densities in detected infections also declined significantly
(Table 4). In the two districts combined, the geometrical
mean parasitaemias were in 2003/51,147 parasites/μl
(range 80 to 341,400) and in 2013/15,230 parasites/μl
(range 53 to 770) among microscopy- and RDT (> 50
parasites/μl)-detectable infections.
The community parasite prevalences determined by
PCR are presented in Table 3. Only P. falciparum and P.
malariae were detected in the five surveys 2005–2015.
The overall ratios between microscopy/RDT- and
PCR-detectable malaria infections were 1:3 in 2005 and
1:8 in 2009–2015 combined. In 2015, the overall mean
parasite prevalence in the two districts was 1.8% (95% CI
1.3–2.3%). This represents an estimated reduction of
92.7% (14-fold) compared with 2003. In the four surveys
2009–2015, the mean PCR determined parasite prevalence
in Micheweni (3.2%) was 2.1 times higher than in North A
(1.5%) (p < 0.001). However, there were opposite trends
(2009–2015) in the prevalences, decreasing in Micheweni
while increasing in North A (p < 0.001). There was no sig-
nificant shift in relative prevalence from younger children
to older age groups over time and throughout the study,
the highest prevalences were seen in children 5–14 years.
In 2005, the prevalences were 13.1% in children < 5 years,
36.4% in 5–14 years and 15.9% in > 14 years. In 2015, the
prevalences were 1.9%, 2.0% and 1.7%, respectively.
In the two districts combined, the main reduction of
PCR-detected P. falciparum occurred from 2005 (20.9%)
to 2009/11 (2.7%) followed by 2.0% in 2013–2015 whereas
the main reduction of P. malariae occurred later, i.e. from
2005 (2.3%) and 2009–2011 (1.1%) to 2013–2015 (0.2%).
Hence, the proportions of P. malariae infections among
detected infections were 11/100 (11%) in 2005, 61/248
(25%) in 2009–2011 and 14/122 (11%) in 2013–2015 (p =
0.0004 for 2009–2011 vs. 2013–2015). The geometric
mean parasite densities in 2009–2015 as determined by
qPCR were 27 (range < 1–7825) parasites/μl among P. fal-
ciparum mono infections and 4 (range < 1–29) parasites/
μl among P. malariae mono infections.
Health facility data
Monthly parasitologically confirmed malaria diagnoses
from health facility outpatients reported between 1999
Table 2 Community prevalences of asexual P. falciparum parasitaemia by microscopy or RDT; all age groups in May/June
Year Micheweni district North A district
Tested Positive Positivity rates (95% CI) Tested Positive Positivity rates (95% CI)
2003 1189 172 14.5% (12.5–16.6) 2167 174 8.0% (6.9–9.3)
2005 1241 135 10.9% (9.2–2.7) 1503 48 3.2% (2.4–4.2)
2006 1182 56 4.7% (3.6–6.1) 1433 12 0.8% (0.4–1.5)
2007 1575 15 1.0% (0.5–1.6) 1499 0 0.0% (0.0–0.2)
2008 2091 10 0.5% (0.2–0.9) 1746 4 0.2% (0.1–0.6)
2009 1539 0 0.0% (0–0.2) 1163 0 0.0% (0.0–0.3)
2011* 1271 10 0.8% (0.4–1.4) 1561 2 0.1% (0.0–0.5)
2013* 1579 7 0.4% (0.2–0.9) 1447 3 0.2% (0.0–0.6)
2015* 1515 9 0.6% (0.3–1.1) 1497 4 0.3% (0.1–0.7)
*Malaria diagnosis by RDT instead of blood slide microscopy
Table 3 Community parasite prevalences (P. falciparum and P. malariae) by PCR; all age groups in May/June
Year Micheweni district North A district
Samples tested Positive Positivity rate (95% CI) Samples tested Positive Positivity rate (95% CI)
2005 190 53 27.9% (21.7–34.9) 288 47 16.3% (12.2–21.1)
2009 1410 72 5.1% (4.0–6.4) 1013 9 0.9% (0.4–1.7)
2011 1378 45 3.3% (2.4–4.4) 1599 22 1.4% (0.9–2.1)
2013 1575 42 2.7% (1.9–3.6) 1448 26 1.8% (1.2–2.6)
2015 1519 26 1.7% (1.1–2.4) 1497 28 1.9% (1.2–2.6)
Linear trends in positivity rates from 2009 to 2015 were statistically significant in Micheweni district (decreasing p < 0.001) and in North A (increasing p = 0.036).
These trends differed by district (interaction) (p < 0.001)
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and 2015 are presented in Fig. 2a–c and Additional file 2:
Table S2. The overall reduction in microscopy/RDT
positivity rate between 2002 and 2015 was 95.7% (from
46.2 to 2.0%) in Micheweni and 89.7% (from 23.3 to
2.4%) in North A. This corresponds to 23- and 10-fold
reductions in the respective districts and a mean reduc-
tion of 94.2% (Table 4).
The main reduction occurred from 2005 when vector
control was implemented in addition to ACT which is
also consistent with the observed cross-sectional parasite
prevalences. Between 2005 and 2008, the prevalence re-
duction was approximately 10-fold, i.e. with an annual
reproductive control rate (Rc) of approximately 0.50,
when estimated as “annual prevalence ratio”. The annual
A
B
C
Fig. 2 Malaria positivity rates among < 5 and ≥ 5 febrile patients in relation to monthly rainfall and interventions. a Febrile patients attending
health care facilities in Micheweni district. b, c Febrile patients attending health care facilities in North A district
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number of parasitologically confirmed malaria patients
in the two districts went from 3528 in 2005, approxi-
mately sixfold down to 578 in 2008, with an annual Rc
of approximately 0.55. From 2003 to 2008, the average
annual Rcs were estimated to 0.50 and 0.63. From 2008
onwards, relatively low microscopy/RDT positivity rates
were observed with averages of 1.8% in Micheweni and
1.2% in North A. The estimated average annual inci-
dences (“Clinical APIs”) during this period were 3.6 and
2.0 (mean 2.8) per 1000 inhabitants for Micheweni and
North A, respectively. Interestingly, there were opposite
trends in the two districts from 2012 (p > 0.001) with
continued decreasing parasite rates in Micheweni (p <
0.01) and increasing rates in North A (p < 0.01) (Add-
itional file 2: Table S2).
A relative shift in parasite positivity rates was observed
towards older age groups between 2002 and 2015
(Fig. 2a–c). Hence, the malaria patients < 5 years of age
represented 47.2% (3067/6502) of all malaria patients in
2002 and 17.3% (125/721) in 2015 (p < 0.001) in the two
districts. There was also a shift from perennial to sea-
sonal malaria (during the main rains) (Fig. 2a–c). Hence,
2001 and 2002, 20% (374/1891) and 28% (380/1377) of
reported malaria cases occurred during the 2 months
with highest numbers whereas in 2014 and 2015 the cor-
responding figures were 44% (142/326) and 41% (128/
316), respectively, i.e. a 1.8-fold increase comparing
2001/2002 to 2014/2015 (p < 0.001).
In Micheweni, prevalences of reported fever within 14
days prior to the cross-sectional surveys were 19% in
2003 and 7% in 2009 (p < 0.01) whereas in North A re-
ported fever remained consistent around 12%. Both dis-
tricts, reported high levels (> 90%) of public facility use,
consistent with findings throughout Zanzibar from
health management information systems in 2009 and
2010. The health facility reporting system lately included
several private facilities and therefore most clinical mal-
aria episodes in the study area.
Risk factors for malaria infections
Risk factors associated with RDT-positivity among fever
patients attending public health facilities, representing
clinical malaria infections, compared to healthy controls,
were assessed in 2015 (Table 5). History of recent travel
(< 1 month) outside Zanzibar (mainly Tanzania main-
land) was reported by 118 (44.2%) malaria-positive fe-
males and 244 (51.3%) malaria-positive males. Reported
travel outside Zanzibar was associated with increased
adjusted ORs of 85.6 (95% CI 50.9–151.4) for females
and 60.3 (95% CI 38.9–96.5) for males, while travel
within Zanzibar was not associated with any increased
risk (adjusted OR, 95% CI 0.7–1.6). The temporal trends
of the malaria cases reporting travel were similar to
those not reporting travel, i.e. highly seasonal. Not sleep-
ing under a bed net was also associated with increased
risk of RDT positivity, adjusted OR 4.4 (95% CI 3.9–6.0),
whereas IRS did not affect malaria risk.
Risk factors associated with asymptomatic PCR posi-
tivity were also assessed in the 2015 cross-sectional sur-
vey (Table 5). There was no evidence to suggest that
malaria infection was significantly associated with travel
outside or inside Zanzibar (past month or within last
year) or with use of any vector control.
All-cause child mortality
The Vital Registry reported all cause annual mortality
rate among children < 5 years in North A district was
1.01% in 2001/2002 before the malaria control
Table 4 Malaria-related indices before interventions (2002–2003) compared to 2015; both districts combined
2002/3 2015 Reduction % (X-fold)
Fever patients in health care facilities
Parasite prevalence by microscopy/RDT 38.2% (95% CI 37.5–39.0) 2.2%, (95% CI 2.0–2.3) 94.2% (17)
Community-based cross-sectional surveys
Parasite prevalence by microscopy/RDT 10.3% (95% CI 9.3–11.4) 0.43% (95% 0.23–0.73) 95.8% (24)
Parasite prevalence by PCR 24.8% (95% CI 23.4–26.3) 1.8% (95% CI 1.3–2.3) 92.7% (14)
Parasite densities
Among microscopy positive or≥ 50 par/μl—geometrical mean par/μl 1135 (Range 115–149,000) 161(Range 53–770) 85.8% (7)
Among all—arithmetical mean par/μl 450* 0.34 99.9% (1324)
Seroconversion rate per year 11% (95% CI 8–13) 0.8% (95% CI 0.6–1.1) 92.1% (14)
Crude under 5 child mortality per year** 1.01% (95% CI 0.84–1.19) 0.36% (95% CI 0.28–0.48) 64.4% (2.8)
Human biting rate per person night*** 12.44* 0.27 97.8% (46)
Entomological inoculation rate (infective bites/year)*** 136* 0.05 > 99.9% (2720)
*In 2005 before intensified vector control
**North A only
***Mean of indoors and outdoors
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interventions (Additional file 2: Table S3). The mortality
rate then decreased to 0.45% in 2005 after introduction
of ACTs in September 2003 and was further reduced to
an annual mean of 0.28% in 2007/2008 after introduc-
tion of ITNs and IRS (Fig. 3). In 2009–2014, the mean
rate was 0.32. This corresponds to a 72% (95% CI 6579)
reduction between 2002 and 2007 and estimated under
5 mortalities of 51 (2001/2) and 14 (2007/8) per 1000
births. The observed decrease was most pronounced in
children aged 1–4 years with an estimated 79% reduction
from an annual mortality rate of 0.53 to 0.11% in 2001/
2002 and 2007/2008 respectively. For children < 1 year,
the corresponding reduction was 67% from 2.93 to
0.96% annual mortality rates.
Table 5 Risk factors in malaria infected asymptomatic and symptomatic individuals in both districts combined in 2015
Healthy, malaria-negative
controls****
Asymptomatic PCR
positive
Unadjusted OR
(95% CI)
Symptomatic RDT
positive
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Total 2938 (100%) 53 (100%) – 743 (100%) – 1 (Ref)
Male 1202 (41%) 29 (55%) 1 (Ref) 476 (64%) 1 (Ref) 1 (Ref)
Female 1736 (59%) 24 (45%) 0.6 (0.3 to 1.0) 267 (36%) 0.4 (0.3 to 0.5) 0.5 (0.4 to 0.6)
Slept under net—yes* 2062 (70%) 33 (62%) 1 (Ref) 286 (38%) 1 (Ref) 1 (Ref)
Slept under net—no 876 (30%) 20 (38%) 1.4 (0.8 to 2.5) 457 (62%) 3.8 (3.2 to 4.5) 4.8 (3.9 to 6.0)
IRS—yes ** 2059 (70%) 43 (81%) 1 (Ref) 492 (66%) 1 (Ref) 1 (Ref)
IRS—no 879 (30%) 10 (19%) 0.5 (0.3 to 1.0) 251 (34%) 1.2 (1.0 to 1.4) 1.2 (1.0 to 1.5)
No travel last month 2658 (90%) 50 (94%) 1 (Ref) 347 (47%) 1 (Ref) 1 (Ref)
Travel inside Zanzibar
last month
233 (8%) 2 (4%) 0.5 (0.1 to 1.5) 34 (5%) 1.1 (0.8 to 1.6) 1.1 (0.7 to 1.6)
Travel outside Zanzibar
last month
47 (2%) 1 (2%) 1.1 (0.1 to 5.3) 362 (49%) 59.0 (43.1 to 82.5) 70.2 (50.0 to 100.6)
No travel outside Zanzibar
last year***
2811 (97%) 51 (98%) 1 (Ref) No data – –
Travel outside Zanzibar
last year
80 (3%) 1 (2%) 0.7 (0.1 to 5.1) No data – –
*Slept last night before survey under a net
**IRS within last year before survey
***Travel from 1 month to 1 year before survey
****Asymptomatic PCR negative individuals in cross-sectional survey
Fig. 3 All-cause mortality in children < 5 years of age in North A district
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Seroconversion and force of infection
Seroprevalences to P. falciparum antigens increased
with age in both settings (Fig. 4a, b). Profile likeli-
hood analysis identified that models with two SCRs
fitted better than a single force of infection with a
change at approximately 5 years of age in the 2009
data and approximately 13 years of age in the 2015
data, consistent with the scale up of interventions be-
tween 2003 and 2006 (Fig. 4a, b). Estimates of force
of infection in 2015 suggest that current SCRs are 10
and 16 fold (90%, 94%) lower than before interven-
tions: North A previous SCR 0.06 year− 1 (95% CI
0.04–0.09), current SCR 0.006 year− 1 (0.004–0.008),
and Micheweni previous SCR 0.16 year.− 1 (0.11–0.23),
current SCR 0.010 year.− 1 (0.007–0.014). The average
current SCR of 0.008 year.− 1 (0.006–0.011) would cor-
respond to an estimated annual parasite incidence
(API) of about 8 cases (between 5 and 20) per 1000
inhabitants.
Entomological findings
In 2005, before the intensified vector control inter-
ventions among 2203 Anopheline mosquitoes col-
lected in the sentinel sites of Unguja and Pemba,
2187 (99%) were An. gambiae s.l., 11 An funestus
and 5 An coustani. In 2010/2011 among 2837 col-
lected anophelines in Micheweni and North A, 2702
(95%) were An. gambiae s.l. and 94 (3%) An. funes-
tus. Other species included An. rivulorum (n = 19),
An. hancocki (n = 8), An. zeimani (n = 8) and An.
maculipalpis (n = 6). Among An. gambiae s.l., there
has been a shift in the longitudinal sentinel sites
from relatively few An. arabiensis in 2005 (6/160;
4%) to becoming predominant 2007–2014 (2907/
3191; 91%) supporting the increasing relative import-
ance of outdoor biting/resting mosquitoes for malaria
transmission (Additional file 1: Figure S2). An. merus
has been the second most frequent subspecies, with
proportion ranging from 1 to 7% in different
Fig. 4 Age-related prevalences of anti-P. falciparum antibodies in Micheweni district (a) and North A district (b)
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collections and years. Larvae collections in 2012/
2013 provided similar findings with 1190/1382 (86%)
An. arabiensis and 113/1382 (8%) An. merus.
In 2005, the mean Anopheline HBRs (in- and outdoor
combined) were 16.30 and 8.57 (mean 12.44) bites/man
night during January to June in Pemba and Unguja, re-
spectively, before the first LLIN distribution. With an
average sporozoite rate of 3.0% (36/1194), the estimated
annual EIRs were 178 and 94 (mean 136) infected bites
respectively, with large fluctuations during the year. In
2015, the mean HBRs were 0.39 and 0.14 (mean 0.26)
on the two islands (Table 4). The indoor HBRs were
0.02 and 0.13 (mean 0.08) bites/man night whereas the
outdoor HBRs were 0.75 and 0.14 (mean 0.45). Assum-
ing a correlation between sporozoite rates and asexual
parasite rates and densities [22], the sporozoite rate in
2015 may be possibly estimated to 60 (20 × 3) times
lower than in 2005, i.e. a mean of 0.05%. The annual
EIRs in 2015 would then be 0.07 and 0.03 (mean 0.05)
on Pemba and Unguja islands respectively.
The average reduction in overall HBR between 2005
and 2015 maybe estimated to 97.8% (Table 4). The esti-
mated mean annual EIRs then decreased from 136 to
0.05 infected bites (Table 4), i.e. over 2000-fold (>
99.9%). In 2015, most bites (65%) occurred during three
peak months (November and April/May) compared to
52% during the same months in 2005.
Pyrethroid resistance was first detected in 2010 in
Pemba [18] and has now spread throughout Zanzibar
[19]. Hence, resistance tests performed 2012–2014 with
different pyrethroids resulted in 24 to 88% and 33 to
82% 24 h (mortality of the main vectors in Unguja and
Pemba, respectively ([15], and new data). In contrast,
bendiocarb and pirimiphos-methyl (Actellic 300CS, Syn-
genta) were still 100% effective against the malaria vec-
tors in 2014 [18].
Rainfall and malaria
The annual rainfall was rather consistent in North A be-
tween 1999 and 2015, with the exception of 2003, 2010
and 2015 (Fig. 2a–c). The mean annual rainfalls for these
3 years were 48%, 28% and 36% lower than the mean an-
nual rainfall (1345 mm). A significant correlation was
observed between monthly rainfalls and confirmed mal-
aria diagnoses from 2007 to 2015 (Pearson correlation
coefficient [rp] = 0.37, p < 0.01), but not in the previous
period of monitoring (1999–2006) ([rp] =0.04, p = 0.78
and [rp] = 0.33, p = 0.11).
Discussion
This study provides an explicitly detailed description of
the decline in malaria transmission in two districts of
Zanzibar over a 12-year period. Reductions of more than
90% were observed in prevalence of infection, incidence
of malaria and human biting rate. A major drop in child
mortality was seen already following the introduction of
ACTs in 2003, whereas the major drop in malaria trans-
mission occurred after the introduction of vector control
in 2005.
Coverage and sustainability of malaria control
interventions
An overall good access to public health care, a continu-
ous supply and adherence to RDTs and ACTs [23–25] as
well as sustained ACT efficacy [26, 27] have supported a
continued efficient management of clinical malaria epi-
sodes in all age groups.
Quite high and sustained coverage of effective vector
control has been achieved, generally higher than in other
sub-Saharan countries according to their national re-
ports [1]. Iterated household level distributions of LLINs
with health information have resulted in consistently
high degrees of reported use in children < 5 years and
other age groups. Combined with high coverage of IRS,
this appears to have had a significant (almost 100-fold)
effect on the indoor vectorial capacity, as may be fore-
casted [28, 29]. Both interventions are publically per-
ceived as beneficial against malaria and biting insects in
general [30, 31]. However, the recent increase in pyreth-
roid resistance represents a major concern [19]. The
more costly carbamate or pirimiphos-methyl has there-
fore replaced pyrethroids in IRS whereas the pyrethroid
impregnated LLINs may still provide relative protection
[32, 33]. Additionally, the change in biting behaviour of
malaria vectors suggests outdoor malaria transmission
poses another challenge to malaria elimination in Zanzi-
bar. A similar shift in species proportions has been re-
ported in other areas of Africa following wide-scale
LLINs use and IRS programmes [34–37]. Complemen-
tary antivectorial efforts targeting both pyrethroid resist-
ant and outdoor resting mosquitoes are clearly required
for successful malaria elimination in Zanzibar.
Malaria transmission impact
The initial rapid reduction in transmission from 2005 to
2007 in the two study districts [8] (annual Rc about 0.5)
was followed by a much slower decline with persistent
low-level transmission from 2008 onwards. Although we
focussed on two districts only, they appeared to be rep-
resentative for all of Zanzibar. The malaria positivity
rates in febrile patients reported from the health facil-
ities in the other eight districts were quite similar to the
rates in the two study districts during the study period
[14]. A new equilibrium of malaria pre-elimination stage
transmission thus appears established despite continuing
high community uptake of the conventional control
interventions.
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The reductions in malaria indices in Zanzibar are
much more pronounced (around 5- to 10-fold higher)
than those reported from other areas/countries of
sub-Saharan Africa including Tanzania mainland [1, 38–
43]. In addition, these gains appear to be more sustained
in Zanzibar than in many other areas where a tendency
of resurgence may be occurring in the latest years [1].
This highlights the uniqueness of the malaria elimin-
ation efforts in Zanzibar. There are probably multiple
reasons for the effectiveness but we believe a major fac-
tor is higher population-level uptake of the interventions
due in large part to the strong commitment of ZAMEP
and the Zanzibar Government and strong involvement
of the communities. An easy access to health care and
accurate malaria treatment is probably also essential. We
do not believe other general factors such as socioeco-
nomic changes and sudden improvement in health care
may have strongly influenced the impact on the rapid
10- to 100-fold reduction in malaria indices. A
socio-economic development has probably occurred in
Zanzibar as in many other areas of Africa during the
study period, but would only account for a minor part of
the malaria control impact.
The establishment of this new persistent level of low
transmission contrasts with the malaria elimination
feasibility report for Zanzibar based on mathematical
modelling which predicted a possible annually continu-
ous Rc of 0.5 and elimination achieved by 2020 if effect-
ive intervention coverage was kept at approximately 75%
[44]. There may be several reasons why this prediction
became unrealistic. Firstly, malaria transmission is now
more seasonal and geographically heterogeneous with
clear foci of infection [14], which may be driving current
transmission [45]. Secondly, sensitive molecular testing
by PCR has highlighted the major reservoir of
low-density asymptomatic parasitaemias across all age
groups, which appears consistent with other low trans-
mission areas [46–48]. Importantly, these low-density
parasitaemias may contribute significantly to the residual
ongoing transmission [49, 50] and interestingly this ap-
pears to be possible despite a major decline in HBRs
(Table 4). An additional interesting finding was that the
relative proportion of low-density P. malariae infections
increased after the initiation of interventions up to 2011.
This may reflect greater longevity of untreated asymp-
tomatic P. malariae than P. falciparum infections [51]
but relatively lower presently ongoing transmission.
Thirdly, imported malaria may represent a major hin-
drance for elimination. A relative risk factor for clinical
malaria infection was indeed history of travel outside
Zanzibar. Such travel, mainly to/from Tanzania main-
land, was reported by 49% of clinical malaria patients
(OR 70) in 2015. Neither recent nor previous travel were
significant risk factors for asymptomatic infections. In
2010, travel outside Zanzibar was reported by only 9/
121 (7%) malaria-confirmed patients (OR 9) [23]. In
2013, travel outside of Zanzibar was reported by 30% of
reported clinical malaria patients [14]. A tentative inter-
pretation of this may be that an increasingly important
fraction of new clinical infections are acquired from out-
side Zanzibar although still somewhat less than reported
estimates for Zanzibar based on modelling [52]. Con-
versely our cross-sectional data, including the serology
results, may suggest that many infections are locally ac-
quired and possibly asymptomatic and thus remain as
untreated residual infections for a significant period of
time allowing for maintained residual local transmission
[53]. Hence, the official figures in Zanzibar of approxi-
mately 3000 malaria confirmed clinical infections signifi-
cantly underestimate the actual incidence of newly
acquired infections. Such figures may be better reflected
by SCR estimates. Extrapolating the mean SCR for the
two study districts (0.008 year−1) to whole of Zanzibar
would suggest over 10,000 new infections annually.
A fourth reason for the halt in malaria transmission
reduction despite the significant reduction of HBRs is
probably that the residual vector population mainly bit-
ing and resting outdoors is now less affected by indoor
vector control. Hence, not having IRS recently per-
formed was not identified as a major risk factor, while
not sleeping under LLIN was only a risk factor for clin-
ical malaria, again supporting that most transmission
may occur outdoors. It also suggests that the preventive
mass effects of LLIN use and IRS on indoor transmis-
sion are now more significant than the individually pre-
ventive effects. However, the spreading resistance to
pyrethroids [19] and more restricted coverage of IRS
represent challenges for future sustained impact, al-
though the exact epidemiological effects of resistance to
the insecticide in the nets appear to vary [32, 33], and
indoor HBRs presently remain very low in our study
area.
A fifth potential challenge is that malaria immunity is
expected to decline as transmission reduces [54]. An in-
creased proportion of clinical malaria episodes was seen
among patients > 5 years although such age shift was not
yet seen among PCR detected low-density parasitaemias.
These older age groups were previously likely to be clin-
ically immuno-protected through previous repeated ex-
posure. A reason for the relative age shift may however
also be behavioural. Older age groups who remain out-
side in the evening are exposed to more outdoor biting
mosquitoes and may be less prone to use LLINs against
mosquitoes biting indoor. Finally, it may also result from
more frequent travel to mainland Tanzania by older age
groups.
It is commonly stated that it is easier to control/elim-
inate malaria on an island (ex Zanzibar) than in-country
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(e.g. Tanzania mainland). This is may be true for a small
island with a small population [55]. However, we do not be-
lieve this to be a major reason for the high impact on the
two large islands of Zanzibar with populations over half a
million each. There is obviously increased risk of imported
malaria on the African continent between neighbouring
countries through more crossing of borders as well as to
some extent exchange of mosquitoes to nearby areas. But
grossly besides the very border areas there should not be
major differences between the malaria control efforts re-
quired in Zanzibar islands and mainland Tanzania. We
therefore consider the findings and challenges in Zanzibar
highly applicable to other African countries.
Public health impact
The study data provide evidence of a major improve-
ment in child health. A highly significant reduction of all
cause child mortality coincided with the introduction of
ACT whereas the most significant reduction in malaria
incidence occurred after the intensified vector control.
Although there was a trend of reduction in under 5 child
mortality already before 2003, the decline 2003–2005
was clearly more pronounced.
The reported child deaths to the Vital Registry prob-
ably represent an underestimated mortality but we be-
lieve the reporting rate remained rather similar during
years of study, allowing for reasonably valid trend ana-
lysis. In addition, the specifically large mortality reduc-
tion during 2003–2006 cannot be explained by any other
public health intervention at that time in Zanzibar. A
major decrease in crude child mortality was also ob-
served on Bioko Island after massive malaria control in-
terventions [42]. In parallel to our observed mortality
reduction, there was also reduced hospitalisation for se-
vere malaria [56] and major reduction in severe anaemia
requiring blood transfusions to < 5 children [8], a com-
mon severe manifestation of malaria in sub-Saharan Af-
rica. The overall reduction of clinical malaria episodes
resulted in a decline in fever episodes especially in chil-
dren, also noted by their caretakers and thus a good in-
centive for sustained LLIN use [30, 31].
The strong impact on crude mortality may largely be
explained directly by reduced malaria specific mortality
from ACT preventing development of severe malaria
manifestations and the vector control reducing malaria
incidence. It may however also result indirectly from the
general reduction of malaria infection and its associated
anaemia, being a risk factor for severe manifestations of
other concomitant bacterial infections [57], e.g. septicae-
mia [58] or pneumonia.
Additional tools and strategies required
A new low malaria transmission epidemiology has emerged
in Zanzibar with spatial, temporal and demographic foci of
infection. These foci are likely to be influenced by outdoor
transmission and increasing insecticidal resistance, a sub-
stantial asymptomatic parasite reservoir and an apparent in-
creasing number of imported infections. All this necessitates
the addition of new malaria control tools and strategies.
Screening (by RDT) and subsequent preventive treat-
ment of asymptomatic but possible parasite carriers has
now been introduced in households where clinical malaria
episodes have been identified and potentially in the future
within for example 300-m radius [59]. Since 2012, IRS
with carbamate and pirimiphos-methyl has been specific-
ally targeting identified hotspots and larvicing interven-
tions are being trialled in selected foci. Gametocytocidal
single low-dose primaquine is being introduced along with
ACT. General surveillance is also being reinforced by
more comprehensive and regular epidemiological investi-
gations of newly detected and reported cases, as well as
more comprehensive monitoring of entomological insecti-
cide resistance and parasitological drug resistance.
However, other possibly more aggressive approaches
are also needed. This may include screen and treat strat-
egies potentially including new highly sensitive diagnos-
tics [60–62] or targeted mass/focal drug administration
[59, 63] possibly including seasonal chemoprevention
[64, 65]. These actions may be targeted to hotspot areas
[66] and/or population groups at risk of residual parasite
reservoir. Additional vector control targeting An. ara-
biensis populations needs to be implemented, e.g. differ-
ent outdoor mosquito “attract and kill” methods. Case
detection and response also needs further development
to ensure future rapid prevention of outbreaks especially
from imported infections. Since imported malaria repre-
sents a significant barrier to malaria control and elimin-
ation efforts in Zanzibar, several additional preventive
strategies may be considered, especially during high
transmission season. Such interventions may include
chemoprophylaxis to Zanzibar is travelling to mainland,
and mass screening or presumptive treatment of anyone
arriving from mainland. However, formal and informal
exit and/or entry points from/to Zanzibar are numerous
and the efficiency of for example screening and treat-
ment may not be very significant with standard diagnos-
tic tools [61]. This will be explored in Zanzibar in the
near future.
With old reinforced and new introduced interventions,
the Rc presently around 1 may possibly be reduced to
0.5 again. The presently annually reported 3000 clinical
malaria cases and our estimated 10,000 infections would
then be reduced below 10 and a state of elimination po-
tentially achieved by approximately 2026.
Conclusions
Zanzibar has made huge progress towards malaria elim-
ination, differently from most other areas in sub-Saharan
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Africa where recent progress appears difficult to sustain.
However, bending the transmission curve further re-
quires significant thought, impetus and funding. In the
past, there have been attempts to strongly control/elim-
inate malaria in Zanzibar although not as successfully as
now, but malaria has resurged each time due to high
vulnerability and receptivity. Zanzibar is therefore now
embarking on a new roadmap. The data presented and
the obstacles and challenges identified in the present
study suggest that responding to these challenges with
reoriented and new strategies Zanzibar may possibly ac-
celerate the reduction and elimination of local malaria
transmission within a coming 10-year period. This may
then provide a highly wishful proof of elimination con-
cept from a high endemic area. However, clearly, the
global community presently expresses overoptimistic
ambitions regarding the timing of malaria elimination,
relying on views and modelling which grossly underesti-
mate the challenges ahead related to both escaping
mechanisms of the parasite and mosquito as well as op-
erational constraints.
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